Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions

Archive ouverte

Joly, Marine | Conte, Cécile | Cazanave, Charles | Le-Moing, Vincent | Tattevin, Pierre | Delobel, Pierre | Sommet, A | Martin-Blondel, Guillaume

Edité par CCSD ; Oxford University Press -

International audience. Population-based data on the epidemiology of progressive multifocal leukoencephalopathy, its predisposing conditions and mortality rate are lacking, although such data are crucial to raise awareness among clinicians and to lay foundations for future therapeutic trials in immunomodulating therapies. In our study, patients were identified by interrogating the French national healthcare reimbursement database from January 1st, 2008 to December 31st, 2017, using progressive multifocal leukoencephalopathy International Classification of Diseases code and a patient’s selection algorithm. Overall incidence rate, one-year all-cause mortality rate and survival patterns were calculated, and factors associated with death were identified using a multivariate Cox proportional hazards regression model. Our cohort is the largest to date, comprising 584 patients with incident progressive multifocal leukoencephalopathy. The overall incidence in France from 2010 to 2017 was stable during the study period at 0.11 per 100,000 person-years, 95% confidence interval [0.10-0.12]. Predisposing diseases were HIV infection (43.7%), followed by haematological malignancies (21.9%), chronic inflammatory diseases (20.2%), solid organ transplantation (4.3%), solid neoplasm (4.1%), and primary immune deficiency (1.5%). The one-year mortality rate was 38.2%, 95% confidence interval [34.2-42.2]. In multivariate analysis, factors independently associated with death were older age (adjusted hazard ratio 0.33 [0.20-0.53] for patients aged 20 to 40 compared with patients aged over 60), male gender (adjusted hazard ratio 0.73 [0.54-0.99] for females compared with males), and predisposing immunosuppressive disease, with the highest risk for solid neoplasms (adjusted hazard ratio 4.34 [2.25-8.37]), followed by haematological malignancies (adjusted hazard ratio 3.13 [1.85-5.30]) and HIV infection (adjusted hazard ratio 1.83 [1.12-3.00]), compared with chronic inflammatory diseases. Immune reconstitution inflammatory syndrome was notified in 7.0% of patients. In conclusion, incidence of progressive multifocal leukoencephalopathy is stable in France, and HIV infection remains the main predisposing disease. This large size cohort uncovers a higher risk of mortality for male patients compared to females, and the worst prognosis for patients with solid neoplasm, while prognosis in patients with haematological malignancies appeared less dismal than in previous studies.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion